Impressive amount of shares. Curious by voting 'no', how would you expect them to have the structure to uplist and continue to fund their pipeline (unless they are able to surprise with an early partner?). They will also have to consider a potential hostile takeover.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links